ICU Medical Stock Soars 8.09%, Hits Intraday High of $149.48

ICU Medical, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen significant activity today, gaining 8.09% as of November 7, 2025. The stock reached an intraday high of USD 149.48, reflecting a notable uptick in performance compared to the S&P 500, which only managed a 0.13% increase on the same day.
Over the past week, ICU Medical has outperformed the broader market with a 16.71% rise, while the S&P 500 declined by 1.63%. The company's one-month performance also stands strong at 18.68%, contrasting sharply with the S&P 500's modest gain of 0.21%. However, despite these recent gains, ICU Medical has faced challenges over the past year, with a decline of 21.5%, while the S&P 500 has risen by 12.65%.

Financially, ICU Medical maintains a robust EBIT to Interest ratio of 16.14, indicating a strong ability to service its debt. The company also boasts a low debt-equity ratio of 0.50, suggesting solid long-term fundamental strength. However, it has underperformed the market significantly over longer periods, including a 25.55% decline over the past five years.